Recherche
-
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
(Science Immunology. vol. 6, n° 62, 2021-08-19)Article de revueLibre accès -
ESO Guideline on covert cerebral small vessel disease
(European Stroke Journal, 2021-05-11)Article de revueLibre accès -
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
(Journal of Experimental Medicine. vol. 219, n° 11, 2022-11-07)Article de revueLibre accès -
Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes
(Proceedings of the National Academy of Sciences of the United States of America. vol. 120, n° 36, pp. e2302720120, 2023-09-05)Article de revueLibre accès -
A second update on mapping the human genetic architecture of COVID-19
(Nature. vol. 621, n° 7977, pp. E7-E26, 2023-09-01)Article de revueLibre accès